Bachem Releases New Receptor Antagonist, Building Blocks for Peptide Synthesis and Immunology Products

Bachem is continuously expanding and updating its extensive range of products for your research purposes. We are pleased to present our latest product additions, which include the PAC1 receptor antagonist M65, the opioid peptide Gliadorphin-7, additional pseudoprolines, and several high-sensitivity EIA kits for the detection of AF-16, Bombesin, Gliadorphin-7, GRP, Lanreotide and LVV-Hemorphin-7.

Today’s release of 16 new products includes:

Gliadorphin-7

Opioid peptide, which is formed during digestion of the gliadin component of the gluten protein.

  • Gliadorphin-7

PAC1 receptor antagonist M65

  • M65

Building blocks and linkers for peptide synthesis

  • Fmoc-Asn(Trt)-Ser(Psi(Me,Me)pro)-OH
  • Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH
  • Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH
  • Fmoc-Suberol (ramage linker)
  • Z-Homocit-OH

LHRH analog

  • (D-His2)-LHRH

Indigogenic substrate for esterases

  • 5-Bromo-4-chloro-1H-indol-3-yl acetate

NMDA homolog

  • N-Me-D-Glu-OH

Immunology products

  • AF-16 – EIA kit, host: rabbit, high sensitivity
  • Bombesin – EIA kit, host: rabbit, high sensitivity
  • Gliadorphin-7- EIA kit, host: rabbit, high sensitivity
  • GRP (human) – EIA kit, host: rabbit, high sensitivity
  • Lanreotide – EIA kit, host: rabbit, high sensitivity
  • LVV-Hemorphin-7 – EIA kit, host: rabbit, high sensitivity

To view the full list of new products visit our website.

More About This Company